Technology
Health
Biotechnology

OpGen

$0.257
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.004 (-1.49%) Today
-$0.007 (-2.65%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell OpGen and other stocks, options, ETFs, and crypto commission-free!

About OPGN

OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It helps to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). Read More The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

Employees
50
Headquarters
Gaithersburg, Maryland
Founded
2001
Market Cap
4.66M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
197.86K
High Today
$0.2871
Low Today
$0.2436
Open Price
$0.267
Volume
278.69K
52 Week High
$2.41
52 Week Low
$0.2102

Collections

Technology
Health
Biotechnology
Healthcare
2015 IPO
US
North America

OPGN News

ReutersAug 11

Edited Transcript of OPGN earnings conference call or presentation 7-Aug-19 8:30pm GMT

11

OPGN Earnings

-$1.38
-$0.97
-$0.56
-$0.15
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.17 per share
Actual
-$0.15 per share

More OPGN News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.